The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
D001853:Bone Marrow / Q000187:drug effects; D001932:Brain Neoplasms / Q000188:drug therapy; D002330:Carmustine / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004359:Drug Therapy, Combination; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008130:Lomustine / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D008168:Lung / Q000187:drug effects; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; D008130:Lomustine; D002330:Carmustine